Zoldonat 4mg Injection

Zoldonat 4 mg Injection contains Zoledronic acid, a medicine used to treat conditions where bones become weak or are damaged. It is commonly used in osteoporosis, Paget’s disease of bone, and bone complications caused by cancers (such as bone metastasis or multiple myeloma). It helps strengthen bones, reduce bone breakdown, and lower the risk of fractures. It is given as an intravenous (IV) infusion, usually in a hospital or clinic under medical supervision.

Zoledronic acid (Zoldonat 4 mg) plays a key role in strengthening bones by slowing down the activity of cells called osteoclasts, which are responsible for breaking down bone tissue. In conditions like osteoporosis or cancer-related bone disease, bone breakdown becomes faster than bone formation, leading to weak and fragile bones. Zoledronic acid binds strongly to bone tissue and inhibits osteoclast activity, thereby reducing bone loss, increasing bone density, and lowering the risk of fractures.

In cancer patients with bone metastasis, it also helps reduce bone pain, prevent complications such as fractures or spinal cord compression, and maintain better quality of life. By restoring balance between bone formation and bone breakdown, it helps keep bones stronger and more stable over time.

Precaution

• Must be used only under medical supervision.
• Inform doctor if you have:
  • Kidney disease
  • Low calcium levels (hypocalcemia)
  • Severe dehydration
  • Dental problems (risk of jaw bone issues)
• Maintain good oral hygiene and get dental check-ups before long-term therapy.
• Not recommended during pregnancy or breastfeeding unless advised.
• Kidney function tests may be required before each dose.

Storage

• Stored and handled in medical facilities only
• Kept at controlled room temperature before use
• Do not freeze
• Not for self-storage or home use